Spinogenix is a pioneering company in the biotechnology and pharmaceuticals sector, dedicated to developing innovative small molecules that restore synapses. The therapeutics target neurodegenerative, neuropsychiatric, and neurodevelopmental disorders, including ALS, Alzheimer’s, and schizophrenia, aiming to enhance patient quality of life.
Competitors of Spinogenix are Biogen, Amgen, Alnylam Pharmaceuticals, Neurocrine Biosciences, Axovant Gene Therapies, Denali Therapeutics, Sage Therapeutics, ACADIA Pharmaceuticals, Roche.
What does Spinogenix do?
Spinogenix is a pioneering company in the biotechnology and pharmaceuticals sector, dedicated to developing innovative small molecules that restore synapses. The therapeutics target neurodegenerative, neuropsychiatric, and neurodevelopmental disorders, including ALS, Alzheimer’s, and schizophrenia, aiming to enhance patient quality of life.